Press release: Johns Hopkins University to install MILabs VECTor+ SPECT/PET Molecular Imaging System

February 24, 2014

MILabs is pleased to announce that the Johns Hopkins University School of Medicine will install the recently launched MILabs VECTor+ system to expand and further enhance its contributions to translational molecular imaging. The VECTor+ molecular imaging system was chosen due to its ultra-high resolution, quantitative accuracy, sensitivity and scanning speed for single-photon emission computerized tomography (SPECT)and positron emission tomography (PET) experiments while providing the added benefit of true simultaneous SPECT/PET acquisition.

The VECTor+ will be installed in the Johns Hopkins Molecular Imaging Center and Cancer Functional Imaging Core. The system will support existing users and projects currently under way at Johns Hopkins. Utilization of the VECTor+ at Johns Hopkins will be led by Benjamin M. W. Tsui, Ph.D., Professor of Radiology and Director of the Division of Medical Imaging Physics, Department of Radiology, and Martin G. Pomper, M.D., Ph.D., Co-Director of the Johns Hopkins Center for Cancer Nanotechnology Excellence.  The system will be utilized for furthering key projects in brain, cardiac, cancer and musculoskeletal research and will also play a role in the development of new radiopharmaceuticals for SPECT.

MILabs is very excited to have the opportunity to work with Johns Hopkins and for the VECTor+ system to play such a significant role in supporting the development and advancement of biomedical research.

About Johns Hopkins
Johns Hopkins Medicine, headquartered in Baltimore, Maryland, is a $6.5 billion integrated global health enterprise and one of the leading health care systems in the United States. Johns Hopkins Medicine, a nonprofit, virtual enterprise, combines over 124 years of commitment to community care with groundbreaking research, teaching and medical services to patients worldwide. The Johns Hopkins Hospital is the only hospital to have ranked #1 in the nation for 21 years in a row by U.S. News & World Report. The hospital was again ranked #1 in the nation in 2013.  Johns Hopkins scientists receive more federal research support annually (more than $450 million) than counterparts in other U.S. medical schools.

From the 1889 opening of The Johns Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.

https://www.hopkinsmedicine.org

About MILabs
MILabs provides high-end preclinical imaging solutions (SPECT/PET/CT/MR) for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as cancer, cardiac and neurodegenerative diseases and diabetes. U-SPECT+/CT provides the fastest, most sensitive and highest resolution (< quarter mm) small-animal SPECT currently available. Recently MILabs introduced VECTor+ and VECTor+/CT providing extremely user friendly, fully integrated and simultaneous sub-mm PET & SPECT. In collaboration with RS2D, MILabs has also introduced MR+, a very compact cryogen-free preclinical MRI system operating at clinical field strengths that can be operated very well in multi-modal imaging labs.

www.milabs.com

Share on social media

Beckman Institute welcomes new ultra-high-performance PET-CT scanner

Beckman Institute at the University of Illinois, Urbana-Champaign Improves Previous Imaging Functionality with Launch of ...
Read More →

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. ...
Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value ...
Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs ...
Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V ...
Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” ...
Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and ...
Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of ...
Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a ...
Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress ...
Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor ...
Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting ...
Read More →
Scroll to Top